In recent years a number of molecular tools have been reported for use in the human fungal pathogen Candida albicans, including PCR-mediated approaches for gene disruption, conditional expression and epitope tagging. Traditionally these methods have utilised auxotrophic markers, however the availability of auxotrophic markers can be limiting and in some instances their use may also impact on the interpretation of results. As a result the use of positive selection markers has now become more commonplace. Here we report the development and validation of a set of cassettes for PCR-mediated gene tagging and over-expression studies utilising the nourseothricin resistance (CaNAT1) positive selection marker. In particular we have produced cassettes containing yeast enhanced GFP, YFP, CFP, RFP and a combined V5-6xHis epitope tag. The cassettes are engineered for use in PCRmediated gene tagging strategies where insertion is targeted to the 3′ end of the gene of interest. In addition, to facilitate protein functional analysis and genetic suppression studies through the use of over-expression, we have also constructed a promoter replacement cassette containing the ENO1 promoter which is known to be expressed at a high level. These cassettes expand on the range of molecular tools available for working with C. albicans and may also be used in other Candida species that display sensitivity to nourseothricin.
Introduction
Candida albicans, the most common fungal pathogen of humans, causes a wide range of clinical diseases ranging from superficial infections to life-threatening systemic disease in the immunocompromised (Calderone, 2002; Odds, 1988; Perlroth et al., 2007) . Traditionally the molecular analysis of this important pathogen has been hampered by a combination of its obligate diploid nature, lack of exploitable sexual cycle, low transformation efficiency and atypical codon usage (Berman and Sudbery, 2002; Noble and Johnson, 2007) . However, with the development of rapid PCR-mediated strategies for gene targeting (Gerami-Nejad et al., 2001; Wilson et al., 1999; Wilson et al., 2000) efficient genetic tools have now been developed, including methods for epitope tagging. Epitope tags are essential molecular tools enabling protein detection, localisation and purification, and those available in C. albicans to date include the fluorescent protein markers GFP, YFP, CFP, RFP, mCherry and Venus (Gerami-Nejad et al., 2001; Gerami-Nejad et al., 2009 , Reijnst et al., 2011 , alongside the small epitopes FLAG, Myc, HA, V5, GST and poly-His (Gerami-Nejad et al., 2009; Hernday et al., 2010; Lavoie et al., 2008; Schaub et al., 2006) .
Genetic manipulation in C. albicans has traditionally used auxotrophic markers. The first to be developed, and the most commonly used, is URA3 (Fonzi and Irwin, 1993) . However, the expression of URA3 from heterologous loci is now known to impact on virulence and virulence-associated attributes, therefore bringing its use into question (Bain et al., 2001; Brand et al., 2004; Cheng et al., 2003; . Further strains have been developed that allow the use of additional auxotrophic markers such as ADE2, LEU2, ARG4 and HIS1 (Fonzi and Irwin, 1993; Negredo et al., 1997; Noble and Johnson, 2005; Wilson et al., 1999) . However, in general, the range of auxotrophic markers available in common laboratory strains can still be limiting, and the use of auxotrophic markers also precludes the direct analysis of clinical isolates of C. albicans as these strains are not auxotrophic. A potential route around this limitation is the use of positive selection markers, and some are now available for use in C. albicans. The first successfully developed positive selection marker provided resistance to mycophenolic acid (Wirsching et al., 2000a , Wirsching et al., 2000b , Beckerman et al., 2001 . However, the resistance marker is a mutant derivative of the native IMH3 gene, and consequently its homology to the chromosomal copy of IMH3 negatively impacts upon its use in gene targeting approaches. Nourseothricin has since been successfully developed as a positive selection marker, with resistance encoded by the heterologous markers CaNAT1 or SAT1 (Reuss et al., 2004; Roemer et al., 2003; Shen et al., 2005) , and more recently a synthetic hygromycin resistance gene has also been reported to function in C. albicans (Basso et al., 2010) .
In this work we have developed a set of PCR-mediated gene tagging cassettes for C. albicans utilising the nourseothricin resistance marker CaNAT1. In particular we have combined the GFP, YFP, CFP and RFP fluorescent protein tags and a V5-6xHis epitope tag with the CaNAT1 marker. In addition we have developed a constitutive expression system utilising the promoter of the highly expressed enolase gene, ENO1. This will allow the application of over-expression studies for genetic suppression and protein functional analysis. These cassettes increase the range of molecular tools available for working with C. albicans and may potentially be used in other Candida species that display sensitively to nourseothricin.
Materials and Methods

Strains, media and culture conditions
All strains constructed and used in the present study are detailed in Table 1 . C. albicans strains were grown in either YEPD medium (1% yeast extract, 2% mycological peptone, 2% glucose) or SC medium (0.67% yeast nitrogen base, 2% glucose, 0.079% complete supplement mixture [Formedium, Hunstanton, UK]) at 30°C. Uridine (50 µg/ml) was added to media as required. To select for nourseothricin resistance strains were plated on to Sabouraud dextrose agar (1% mycological peptone, 4% glucose, 1.5% Agar) containing 200 µg/ml nourseothricin (Werner BioAgents, Jena, Germany). To induce β-N-acetylhexosaminidase activity strains were grown in SC-GlcNAc (0.67% yeast nitrogen base, 0.079% complete supplement mixture, 25 mM N-acetylglucosamine).
Cassette construction
Fusion PCR (Wach, 1996) was used in the construction of our tagging and overexpression cassettes that incorporate the nourseothricin resistance marker. For the carboxy terminus fluorescent protein tagging cassettes GFP, YFP, CFP, RFP coupled to the CaADH1 terminator were PCR amplified from pGFP-URA3, pYFP-URA3, pCFP-URA3 and pRFP-URA3 (Gerami-Nejad et al., 2001; Gerami-Nejad et al., 2009) respectively with primer pair GFP-F and FP-R-FUS for GFP, YFP and CFP, and primer pair RFP-F and FP-R-FUS for RFP ( Table 2 ). The CaNAT1 resistance marker, under the control of the Ashbya gossypii TEF1 promoter and terminator, was PCR amplified from pJK795 (Shen et al., 2005) using primers NAT1-F-FUS and NAT1-R. To allow for fusion PCR the GFP-R-FUS and NAT-F-FUS oligonucleotides incorporated complementary sequences at the 5′ end. For fusion PCR to generate the full length cassettes the first round PCR products were purified, combined and PCR amplified using primer pairs GFP-F and NAT1-R for the GFP, YFP and CFP cassettes, and RFP-F with NAT1-R for the RFP cassette. All PCR reactions for cassette construction were carried out using Extensor High Fidelity PCR master mix (Thermo Scientific, Epsom, UK). The GFP-NAT1 cassette was cloned into the TOPO TA vector pCR2.1 (Invitrogen, Paisley, UK) and all other cassettes were cloned into StrataClone pSC-A-amp/kan (Agilent Technologies, Stockport, UK) to generate pGFP-NAT1, pYFP-NAT1, pCFP-NAT1 and pRFP-NAT1 (Fig. 1) .
For the over-expression cassette the CaENO1 promoter was amplified from C. albicans genomic DNA using the ENO1-F-FUS and ENO1-R primers. The purified PCR product was combined with the CaNAT1 marker (amplified with NAT1-F-FUS and NAT1-R as previously) by fusion PCR using primers ENO1-R and NAT1-R. To generate the V5-6xHis-NAT1 cassette the V5-6xHis coding region coupled with the ScCYC1 terminator was amplified from pYES2.1 (Invitrogen, Paisley, UK) with primer pair YES-V5-F and CYC-T-R-FUS. The purified product was then fused to the CaNAT1 marker by fusion PCR using the YES-V5-F and NAT1-R primers. The NAT1-ENO1p and V5-6xHis-NAT1 cassettes were then cloned into the TOPO TA vector pCR2.1 (Invitrogen, Paisley, UK) to generate pNAT1-ENO1p and pV5-NAT1.
In addition to the V5-6xHis-NAT1 cassette we also developed a V5-6xHis-URA3 cassette. Briefly, the V5-6xHis coding region and ScCYC1 terminator was amplified from pYES2.1 (Invitrogen, Paisley, UK) with primer pair YES-V5-F and CYC-T-R, and the product cloned into pGEM-T Easy (Promega, Southampton, UK). The insert was then released by NotI digestion and subcloned into the NotI site of CIp10 (Murad et al., 2000) to generate pV5-URA3. The orientation of the V5-6xHis sequence relative to the URA3 marker in CIp10 was confirmed by PCR to allow this vector to act as either an integrative vector or as a template for PCR-mediated gene tagging strategies.
Utilisation of cassettes in strain construction
To utilise the cassettes for PCR-directed gene tagging they were amplified by PCR with primers containing the appropriate gene-specific sequences to drive homologous recombination (Fig. 1 , Tables 2 and 3 ). The standard amplification protocol used Thermoprime Master Mix (Thermo Scientific, Epsom, UK) and cycling conditions of an initial denaturation of 3 min at 94°C, followed by 30 cycles of 94°C 1 min, 55°C 1min and 72°C 3 min, and a final extension at 72°C for 5 min. Typically 50 µl of unpurified PCR product was then used to transform C. albicans using standard methodologies (Gietz and Woods, 2002) . Following transformation cells were incubated in YEPD at 30°C for 4 h to allow expression of the CaNAT1 marker before plating onto selective media. Correct integration of the cassettes was confirmed by colony PCR (Linder et al., 1996) using a primer within the cassette and a second targeting the chromosomal integration site outside the region included in the original targeting primer.
To confirm function of the GFP, YFP, CFP and RFP cassettes they were amplified with gene-specific sequences to target them to the CaACT1 locus immediately downstream of its promoter (primers ACT1-GFP-F and ACT1-FP-R for GFP, YFP and CFP; ACT1-RFP-F and ACT1-FP-R for RFP; Tables 2 and 3 ). The amplified cassettes were transformed into the Ura + strain NGY152 and correct integration was confirmed by colony PCR (primers ACT1-S and GFP-UP for GFP, YFP and CFP; ACT1-S and RFP-UP for RFP; Tables 2 and 3 ). To tag CDC3 the GFP-NAT1 cassette was amplified with CDC3-GFP-F and CDC3-FP-R and transformed into the clinical isolate SC5314. Correct integration was confirmed by PCR with primer pair GFP-UP and CDC3-S.
To test the ENO1p over-expression and V5-6xHis cassettes the HEX1 gene encoding β-N-acetylhexosaminidase was targeted. For over-expression the NAT1-ENO1p cassette was amplified using HEX-ENO-F and HEX-ENO-R primers and transformed into strain NGY152, to replace the native promoter of one allele with the ENO1 promoter. Correct integration was confirmed by PCR screening using the ENO-SF and HEX-ENO-S primers. To introduce the C-terminal V5-6xHis epitope tag into Hex1p the V5-6xHis-NAT1 and V5-6xHis-URA3 cassettes were amplified with Hex-V5-F and either HEX1-V5-NAT1-R or HEX1-V5-URA3-R respectively. The CaNAT1-containing cassette was transformed into NGY152 and the URA3-containing cassette into the ura -strains CAI-4 or NGY98 (∆pmr1/∆pmr1). Correct genomic integration was determined using primer pair HEX-V5-S and V5-S.
Protein detection methods
For microscopy studies strains were grown to logarithmic phase, briefly washed in PBS and viewed either live or following a short (10 min) fixation in 70% ethanol. Epifluorescence and differential interference microscopy was carried out using a motorised inverted IX81 microscope (Olympus, Southend-on-Sea, UK) with epifluorescence illumination for GFP (Ex460/40, BS495, Em525/50), YFP (Ex500/24, BS520, Em542/27), CFP (Ex436/20, BS455, Em480/40) and RFP (Ex562/40, BS593, Em624/40). Filter sets were from Chroma (Rockinham, USA) or Semrock (Rochester, USA), and digital images were captured using a CoolSnap HQ2 camera (Roper Scientific, Germany) and processed using Metamorph software (version X; Molecular Devices, Wokingham, UK).
Protein extracts were prepared in 100 mM Tris-HCl pH 7.5, 0.01% SDS, 1 mM dithiothreitol, 10% glycerol containing protease inhibitors (Roche Applied Science, Burgess Hill, UK) by glass bead disruption in a FastPrep machine (Qbiogene, Cambridge, UK). The resulting lysate was clarified by centrifugation at 21500 g for 10 min. Prior to western blotting, 50 µg of protein extracts were separated on a 10% NuSep Tri-HEPES-SDS gel (Generon, Maidenhead, UK) before blotting on to a polyvinylidene difluoride membrane. The membrane was blocked with 5% bovine serum albumin in TBS-T (Tris-buffered saline containing 0.01% Tween 20) for 2 h, before probing with the mouse anti-V5 primary antibody (Invitrogen, Paisley, UK) at a 1:5000 dilution for 1 h. The membrane was then washed three times in TBS-T prior to incubation with the secondary antibody, anti-mouse IgG-horseradish peroxidase (Invitrogen, Paisley, UK), at 1:10000 dilution for 1 h. Following a final four washes in TBS-T, proteins were detected using Lumiglo (New England Biolabs, Hitchin, UK) according to manufacturer's instructions.
For protein purification, using the 6xHis tag, protein extracts were prepared in 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 0.1% Tween-20, 1 mM β-mercaptoethanol, 10%
Glycerol, 10 mM Imidazole by glass bead disruption. Hex1-V5-6xHis was then batch purified from 20 mg of protein extract using Ni-NTA agarose beads as per manufacturer's instructions (QIAGEN, Crawley, UK) with proteins eluted in 50 mM Tris-HCl pH 7.5, 300 mM Imidazole.
Hex1p activity was determined by a modified version of the assay used by Cannon et al., (1994) . Briefly, protein extracts were incubated with the substrate pNPGlcNAc (1.25 mM; Glycosynth, Warrington, UK) in 0.1 M citrate/KOH buffer pH 4 for 30 min at 37 °C. Reactions were stopped by the addition of 1 M Na 2 CO 3 and absorbance at 420 nm determined. Hex1p activity was expressed as nmol pnitrophenol released per min per mg protein.
Results and Discussion
Construction of PCR tagging cassettes
To facilitate the analysis of gene function in C. albicans we constructed gene tagging and over-expression cassettes incorporating the CaNAT1 positive selection marker for nourseothricin resistance (Shen et al., 2005 (Fig. 1) . In addition we also generated cassettes containing a C-terminal V5-6xHis epitope tag for use in protein analysis, and a cassette containing the enolase promoter (ENO1p) for driving constitutive over-expression of the target gene (Fig. 1) . Full details of the cassette construction are given in the Materials and Methods. The nourseothricin resistance marker used in this work (Shen et al., 2005) is under the control of the heterologous Ashbya gossypii TEF1 promoter and terminator, thereby avoiding problems associated with the misdirection of gene targeting when native control sequences are used.
Gene tagging using these cassettes follows standard protocols; cassettes are PCR amplified using oligonucleotide primers containing 70 bp of homology to the target gene to direct integration (Table 3 ). This level of homology produces a reasonable proportion of transformants in which integration has occurred at the desired target site. All the gene tagging cassettes use a common reverse primer, and the GFP, YFP and CFP cassettes also share a common forward primer. For selection of nourseothricin resistant transformants we found that a minimum of four hours growth in non-selective medium was required post transformation to allow expression of the CaNAT1 marker, similar to previous reports on the use of the SAT1 marker (Reuss et al., 2004) . However, in our hands selection on Sabouraud dextrose medium with 200 µg/ml nourseothricin proved the most reliable, and required the use of lower concentrations of nourseothricin than other media.
Validation of fluorescent protein fusion cassettes
To confirm the four fluorescent protein tagging cassettes (GFP, YFP, CFP and RFP; Fig. 1 ) were functional we integrated each cassette immediately downstream of the start codon of the constitutively expressed ACT1 gene. Cassettes were amplified and transformed into the prototrophic strain NGY152. Nourseothricin resistant colonies appeared 1-2 days post transformation and correct genomic integration at the ACT1 locus was confirmed by colony PCR. Fluorescence microscopy clearly demonstrated that all four cassettes were functional, with cells displaying bright fluorescence throughout the cytoplasm with some exclusion from the vacuole ( Fig.  2A) . No bleed-through between filter sets was apparent, consistent with the potential use of these fluorescent proteins for co-localisation and co-expression studies.
The CaNAT1 and SAT1 markers have previously been shown to function in clinical isolates of C. albicans (Reuss et al., 2004; Shen et al., 2005) . We targeted the GFP-NAT1 cassette to tag the septin Cdc3 in the SC5314 clinical isolate. Fluorescence imaging of the tagged strain clearly demonstrated the characteristic cell cycledependent localisation of Cdc3 (Gerami-Nejad et al., 2001; Warenda and Konopka, 2002) to the mother-bud neck (Fig. 2B) . In addition the GFP-NAT1 cassette has also been successfully used to visualise spindle pole body proteins that are expressed at a low level (Milne, Cheetham, Bates in preparation).
Validation of epitope tagging and constitutive over expression cassettes
The epitope tagging cassettes contain both a V5 and C-terminal 6xHis epitope tag, combined with either the CaNAT1 nourseothricin resistance marker or the URA3 auxotrophic marker. This combination of epitopes only increases protein size by 3.7 kDa and offers the benefits of efficient detection through the V5 epitope and protein purification using the 6xHis epitope. To test the function of both the V5-6xHis-NAT1 and V5-6xHis-URA3 cassettes they were targeted to tag HEX1 in the NGY152 and CAI-4 strains respectively. HEX1 encodes β-N-acetylhexosaminidase, a well characterised hydrolytic enzyme whose expression is induced in medium containing GlcNAc as the sole carbon source (Cannon et al., 1994; Niimi et al., 1997) . Tagged strains were grown in inducing and non-inducing conditions, and proteins were extracted and analysed by western blotting using an anti-V5 antibody. As expected, only when grown on GlcNAc was Hex1 expressed and it was clearly detectable as both an unmodified (67 kDa) and heavily glycosylated form (~125 kDa) in soluble protein extracts (Fig. 3A) . We also tested the V5-6xHis-URA3 cassette by tagging Hex1 in a Capmr1∆ mutant which is known to demonstrate glycosylation defects (Bates et al., 2005) . In this mutant the glycosylated form of the tagged Hex1 protein displayed a clear increase in its electrophoretic mobility, a defining characteristic of the mutant's gross defect in glycosylation (Fig. 3B) . In addition to the V5 tag for protein detection the cassettes also contain the 6xHis epitope which can be employed in protein purification using standard methods. To confirm this epitope is functional we used it to successfully purify Hex1p-V5-6xHis from soluble protein extracts (Fig. 3C ).
The HEX1 gene was also targeted to validate the NAT1-ENO1p constitutive overexpression cassette. The ENO1 promoter was chosen as it has been shown to be expressed at high levels, and it has previously been demonstrated to be suitable for gene-overexpression studies (Bates et al., 2007; . The cassette was targeted to replace the native promoter of one copy of the HEX1 gene, and expression monitored through determining Hex1 enzyme activity. The assay results confirmed that HEX1 is only expressed in wild type cells in the presence of GlcNAc, consistent with previous observations. Replacing the endogenous HEX1 promoter with the NAT1-ENO1 promoter cassette resulted in the clear over-expression of Hex1 under both inducing and non-inducing conditions (Fig. 3D) . Therefore the NAT1-ENO1p cassette is capable of driving high level gene expression which may be useful for both the functional analysis of proteins and in studying genetic interactions through epistasis-based approaches.
Conclusion
In summary we have developed a set of cassettes for tagging and over-expression studies in C. albicans utilising the positive selection marker CaNAT1 for nourseothricin resistance. These cassettes complement and extend the range of molecular cell biology tools currently available for use in this important pathogen. In addition these cassettes will be of potential use in other Candida species, or indeed in other fungi, that display sensitivity to nourseothricin. (Gillum et al., 1984) CAI-4 -ura3∆::imm434/ura3∆::imm434 (Fonzi and Irwin, 1993) NGY152 CAI-4
As CAI-4 but RPS1/rps1∆::CIp10 (Brand et al., 2004) ) ; grey boxes, GFP, YFP, CFP, RFP, V5-6xHis or ENO1 promoter (ENO1p) sequences; white boxes, terminator sequences (CaADH1 t or ScCYC1 t ).The CaNAT1 marker is under the control of the heterologous Ashbya gossypii TEF1 promoter and terminator as originally described (Shen et al., 2005) . The GFP-NAT1, V5-6xHis-NAT1 and NAT1-ENO1p cassettes were cloned into pCR2.1 (Invitrogen); YFP-NAT1, CFP-NAT1, RFP-NAT1 cassettes into pSC-A-amp/kan (Strataclone); and the V5-6xHis-URA3 cassette was cloned into CIp10 (Murad et al., 2000) . Oligonucleotide primers used to amplify cassettes are described in the Materials and Methods and Tables 2 and 3. 
